These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23987164)

  • 1. A retrospective review of office-based 532-nm GreenLight laser prostatectomy in men with symptomatic benign prostatic hyperplasia.
    Osterberg EC; No D; Otto BJ; Naftali I; Choi BB
    Urology; 2013 Sep; 82(3):680-4. PubMed ID: 23987164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate outcomes of GreenLight HPS™ laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia.
    Gu X; Strom K; Spaliviero M; Wong C
    J Endourol; 2011 Jun; 25(6):1037-41. PubMed ID: 21574860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of 180W XPS GreenLight laser vaporization of the prostate for treatment of benign prostatic hyperplasia.
    Tao W; Sun C; Yang D; Zang Y; Zhu J; Zhang Y; Wang G; Xue B
    J Xray Sci Technol; 2019; 27(6):1121-1129. PubMed ID: 31498146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes < 60 cc, 60 cc-100 cc and > 100 cc.
    Hueber PA; Ben-Zvi T; Liberman D; Bhojani N; Gautam G; Deklaj T; Katz M; Zorn KC
    Can J Urol; 2012 Oct; 19(5):6450-8. PubMed ID: 23040627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.
    Bachmann A; Tubaro A; Barber N; d'Ancona F; Muir G; Witzsch U; Grimm MO; Benejam J; Stolzenburg JU; Riddick A; Pahernik S; Roelink H; Ameye F; Saussine C; Bruyère F; Loidl W; Larner T; Gogoi NK; Hindley R; Muschter R; Thorpe A; Shrotri N; Graham S; Hamann M; Miller K; Schostak M; Capitán C; Knispel H; Thomas JA
    Eur Urol; 2014 May; 65(5):931-42. PubMed ID: 24331152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study.
    Kwon O; Lee HE; Bae J; Oh JK; Oh SJ
    Urology; 2014 Mar; 83(3):581-5. PubMed ID: 24373317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Research Office of the Endourological Society Global GreenLight Laser Study: Outcomes from a contemporary series of 713 patients.
    de la Rosette J; Elhilali M; Naito S; Unal D; Razvi H; Liatsikos E; Bachmann A; Tubaro A; Alivizatos G; Mak SK; Badlani G; Eltahawy E; Wong C; Telich Vidal M; Te A; d'Ancona F; Arum CJ; Gutierrez J;
    Int J Urol; 2015 Dec; 22(12):1124-30. PubMed ID: 26307430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short term outcomes of GreenLight vapor incision technique (VIT) of the prostate: comparison of outcomes to standard GreenLight 120W HPS vaporization in prostate volumes greater than 80 cc.
    Ben-Zvi T; Hueber PA; Abdollah F; Liberman D; Bhojani N; Gautam G; Zorn KC
    Can J Urol; 2013 Feb; 20(1):6633-9. PubMed ID: 23433136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
    Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A
    BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
    Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
    Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BiVap saline vaporization of the prostate in men with benign prostatic hyperplasia: our clinical experience.
    Karakose A; Aydogdu O; Atesci YZ
    Urology; 2014 Mar; 83(3):570-5. PubMed ID: 24275275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid ambulatory pathway laser prostatectomy is safe: results within the global period.
    Jumper C; Snyder P; Yap RL
    BJU Int; 2012 Oct; 110(8):1190-3. PubMed ID: 22372831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Surgical Outcomes with Photoselective GreenLight XPS Laser Vaporization of the Prostate in High Medical Risk Men with Benign Prostatic Enlargement: A Multicenter Study.
    Rajih E; Tholomier C; Hueber PA; Alenizi AM; Valdivieso R; Azizi M; Gonzalez RR; Eure G; Kriteman L; Hai M; Zorn KC
    J Endourol; 2017 Jul; 31(7):686-693. PubMed ID: 28443721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoselective vaporization of the prostate with GreenLight HPS 120-W laser for benign prostatic hyperplasia: 36 months' follow-up.
    Zang Y; Xue B; Zhang Y; Yang D; Gao J; Sun C; Cui Y; Tao W; Chen D; Shan Y
    Urol Int; 2012; 89(2):203-7. PubMed ID: 22797005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures.
    Bachmann A; Muir GH; Collins EJ; Choi BB; Tabatabaei S; Reich OM; Gómez-Sancha F; Woo HH
    Eur Urol; 2012 Mar; 61(3):600-7. PubMed ID: 22153927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
    Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
    BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of GreenLight XPS Laser Vapoenucleation in Prostates Measuring Over 150 mL.
    Stone BV; Chughtai B; Forde JC; Tam AW; Lewicki P; Te AE
    J Endourol; 2016 Aug; 30(8):906-12. PubMed ID: 27203515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of ambulatory laser vaporization of the prostate for benign prostatic hyperplasia.
    Berquet G; Corbel L; Della Negra E; Huet R; Trifard F; Codet Y; Boulière F; Verhoest G; Vincendeau S; Bensalah K; Mathieu R
    Lasers Surg Med; 2015 Jul; 47(5):396-402. PubMed ID: 25997558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.